Evidence map›Paper›PMID 39060857›Full record

ArticleMolecular diversity2025

Pyrazoline Spiro-oxindole tethered 1,2,3-triazole hybrids: Design, synthesis, antimicrobial efficacy and molecular modelling studies.

Akanksha Bhukal, Vijay Kumar, Anirudh Pratap Singh Raman, Anil Kumar, Prashant Singh, Kashmiri Lal

Abstract read
PubMed Publisher
In one paragraph

Article in Molecular diversity, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Akanksha BhukalDepartment of Chemistry, Guru Jambheshwar University of Science & Technology, Hisar, Haryana, 125001, India.
Vijay KumarDepartment of Chemistry, Guru Jambheshwar University of Science & Technology, Hisar, Haryana, 125001, India.
Anirudh Pratap Singh RamanDepartment of Chemistry, Atma Ram Sanatan Dharma College, University of Delhi, New Delhi, India.
Anil KumarDepartment of Biotechnology, Guru Jambheshwar University of Science & Technology, Hisar, Haryana, 125001, India.
Prashant SinghDepartment of Chemistry, Atma Ram Sanatan Dharma College, University of Delhi, New Delhi, India.
Kashmiri LalDepartment of Chemistry, Guru Jambheshwar University of Science & Technology, Hisar, Haryana, 125001, India. klal_iitd@yahoo.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Inspired from the important applications of spirocyclic compounds in medicinal chemistry, a new series of pyrazoline Spiro-oxindole tethered 1,2,3-triazole hybrids was reported via Cu(I)-catalyzed click reaction from isatin-pyrazoline linked terminal alkynes with in situ derived benzyl azides. Antimicrobial evaluation data showed that all hybrids exhibited promising efficacy towards the tested microbial strains. Antimicrobial screening as well as docking studies suggested that hybrid 6a was found to be most potent towards Aspergillus niger (MIC = 0.0122 μmol/mL) and Escherichia coli (MIC = 0.0061 μmol/mL). Molecular docking studies of 6a within the binding pockets of antibacterial and antifungal targets revealed good interactions with the binding energies of - 144.544 kcal/mol and - 154.364 kcal/mol against 1KZN (E. coli) and 3D3Z (A. niger), respectively. Further, MD simulations were performed to study the stability of the complexes formed at 300 K. Based on the RMSD trajectories, it is evident that 3D3Z-6a complex exhibits minimal deviation, whereas the 1KZN-6a complex displayed little more deviation compared to the protein but, both are in acceptable range. Moreover, 3D3Z-6a and 1KZN-6a showed maximum number of hydrogen bonds at 50 ns and 70 ns, respectively, thereby complementing the stability of these complexes.

Indexed as

Anti-Bacterial AgentsAnti-Infective AgentsDrug DesignOxindolesPyrazolesSpiro CompoundsTriazolesAntifungal AgentsAspergillus nigerEscherichia coliMicrobial Sensitivity TestsModels, MolecularMolecular Docking SimulationMolecular Dynamics SimulationStructure-Activity RelationshipAnti-Bacterial AgentsAntifungal AgentsAnti-Infective AgentsOxindolesPyrazolesSpiro CompoundsTriazoles1,2,3-Triazole hybridAntimicrobialDocking StudiesIsatinMolecular dynamicsPyrazoline

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.